LRRK2 G2019S in the North African population: a review.

Select type


Benamer HT 1, de Silva R 2.

1-Department of Neurology, New Cross Hospital, Wolverhampton, and 2-Department of Neurology, Essex Centre for Neurological Sciences, Queen’s Hospital, Romford, UK

Eur Neurol. 2010;63(6):321-5.


Parkinson’s disease (PD) is a common neurodegenerative disorder, for which environmental and/or genetic factors are postulated as possible causes. Over the past decade there has been a substantial increase in the knowledge of the genetics of PD. Mutations in Leucine-rich repeat kinase 2 (LRRK2) are the most frequent genetic causes of PD, and the common G2019S mutation has been identified in various ethnic groups with variable frequency. The aim of this article is to review the literature relating to LRRK2 G2019S in the North African population, which is composed of two main ethnic groups – the Berbers and the Arabs. The frequency of LRRK2 G2019S is 30–41% in familial PD and 30–39% in apparently sporadic PD in North Africa. Within healthy controls, Moroccan Berbers appear to have the highest carrier frequency at 3.3%. The majority of the available studies do not draw a clear distinction between the two ethnic groups, despite the distinct possibility that their ancestral origins are different. Further research looking at the respective prevalences of LRRK2 G2019S in Berbers and Arabs, and in different Arab populations, seems justified.

Keywords: LRRK2 G2019S in the North African population